Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB04865_DB08895_nanopub.RAVLHwA6ew5R6YlwUzOGxpSmHBpYVvi6F3A8epk6eQEMw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB04865_DB08895 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB04865_DB08895 label "DDI between Homoharringtonine and Tofacitinib - Avoid combination with tofacitinib and other potent immunosuppressants as there is potential to increase the immunosuppressant effects. Other less potent immunosuppressants such as methotrexate, at antirheumatic doses, and other non-disease modifying antirheumatic drugs (non-DMARDs) can be combined. [drugbank_resource:DB04865_DB08895]" assertion.
- drugbank_resource:DB04865_DB08895 identifier "drugbank_resource:DB04865_DB08895" assertion.
- drugbank_resource:DB04865_DB08895 title "DDI between Homoharringtonine and Tofacitinib - Avoid combination with tofacitinib and other potent immunosuppressants as there is potential to increase the immunosuppressant effects. Other less potent immunosuppressants such as methotrexate, at antirheumatic doses, and other non-disease modifying antirheumatic drugs (non-DMARDs) can be combined." assertion.
- drugbank:DB08895 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB04865_DB08895 assertion.
- drugbank:DB04865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB04865_DB08895 assertion.